Protective Effect of Xinjiang Bactrian Camel Milk on the Liver of Streptozotocin-Induced Diabetic Mice

被引：0
|
作者：
Liu C. [1 ]
Feng X. [1 ]
Dou Z. [1 ]
An S. [1 ]
Liu M. [1 ]
Hou Z. [2 ]
Yang J. [1 ]
机构：
[1] College of Life Science and Technology, Xinjiang University, Ürümqi
[2] Department of Geriatrics, The Second Affiliated Hospital of Xinjiang Medical University, Ürümqi
来源：
Yang, Jie (yangjie234@xju.edu.cn) | 1600年 / Chinese Chamber of Commerce卷 / 41期
关键词：
Camel milk; Liver injury; Peroxisome proliferator-activated receptor γ; Sterol regulatory element binding protein 1c; Type; 1; diabetic;
D O I：
10.7506/spkx1002-6630-20190322-293
中图分类号：
学科分类号：
摘要：
In this research, the effect of whole milk, skim milk, milk casein, whey and whey proteins from bactrian camels in Xinjiang on glycolipid metabolism, antioxidant status, hepatocyte morphology, and the mRNA expression of peroxisome proliferator-activated receptor gamma (PPAR-γ) and sterol regulatory element binding protein 1c (SREBP1c) in streptozotocin (STZ)-induced type 1 diabetic mice was investigated. The results showed that all samples except camel milk casein could increase the body mass of diabetic mice, reduce blood sugar, increase serum insulin level, restore blood lipid levels to normal, improve liver antioxidant capacity, and reduce liver tissue damage. In terms of these indicators, the whey treatment group differed more significantly from the model group than did other treatment groups (P < 0.01). Camel whey could increase the expression of PPAR-γ and reduce the expression of SREBP1c in the liver of diabetic mice. In summary, camel whey could effectively improve glycolipid metabolism and relief liver tissue damage in STZ-induced diabetic mice and its effect might be related to the up-regulation of PPAR-γ and the down-regulation of SREBP1c. © 2020, China Food Publishing Company. All right reserved.
引用
收藏
页码：74 / 80
页数：6
相关论文
共 30 条
  • [1] IBRAHIM H R, ISONO H, MIYATA T., Potential antioxidant bioactive peptides from camel milk proteins, Animal Nutrition, 4, 3, pp. 37-44, (2018)
  • [2] YANG J, DOU Z H, PENG X, Et al., Transcriptomics and proteomics analyses of anti-cancer mechanisms of TR35: an active fraction from Xinjiang bactrian camel milk in esophageal carcinoma cell, Clinical Nutrition, 38, 5, pp. 2349-2359, (2019)
  • [3] SINGH R, MAL G, KUMAR D, Et al., Camel milk: an important natural adjuvant, Agricultural Research, 6, 4, pp. 327-340, (2017)
  • [4] MOHAMAD R H, ZEKRY Z K, ALMEHDAR H A, Et al., Camel milk as an adjuvant therapy for the treatment of type 1 diabetes: verification of a traditional ethnomedical practice, Journal of Medicinal Food, 12, 2, pp. 461-465, (2009)
  • [5] ISMAIL T, AHMAD Z, SESTILI P, Et al., Camel's milk concentrate inhibits streptozotocin induced diabetes, Food Bioscience, 26, pp. 73-79, (2018)
  • [6] AGRAWAL R P, BUDANIA S, SHARMA P, Et al., Zero prevalence of diabetes in camel milk consuming Raica community of north-west Rajasthan, India, Diabetes Research & Clinical Practice, 76, 2, pp. 290-296, (2007)
  • [7] MOHAMMADDIN A, ROHRA D K, MORTAJA S, Et al., Effects of camel milk in dyslipidaemia: a randomised clinical trial, International Dairy Journal, 84, pp. 79-84, (2018)
  • [8] 1, pp. 42-43
  • [9] SHIMA T, UTO H, UEKI K, Et al., Clinicopathological features of liver injury in patients with type 2 diabetes mellitus and comparative study of histologically proven nonalcoholic fatty liver diseases with or without type 2 diabetes mellitus, Journal of Gastroenterology, 48, 4, pp. 515-525, (2013)
  • [10] SU Q, SUN F, LI J, Et al., The correlation analysis of primary liver cancer with type 2 diabetes[J], Indian Journal of Cancer, 52, pp. 148-152, (2015)
123